P-Selectin Glycoprotein Ligand 1 (SELPLG) Antibody (FITC)

Este producto es parte de SELPLG - selectin P ligand
P-Selectin Glycoprotein Ligand 1 (SELPLG) Antibody (FITC)
442€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
P-Selectin Glycoprotein Ligand 1 (SELPLG) Antibody (FITC)
Category
Primary Antibodies
Provider
Abbexa
Reference
abx415310
Tested Applications
FCM

Description

P-Selectin Glycoprotein Ligand 1 (CD162) Antibody (FITC) is a Rat Monoclonal antibody against P-Selectin Glycoprotein Ligand 1 (CD162).

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: P-Selectin Glycoprotein Ligand 1 (SELPLG)
Host
Rat
Reactivity
Mouse
Detection Method
Laser Line: 488
Excitation/Emission: 499/515
Assay Type
Concentration: 0.1 mg/ml
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
FITC
Isotype
IgG2a
Purification
Purified
Size 1
100 µg
Form
Liquid
Tested Applications
FCM
Buffer
PBS, 1% BSA. Contains sodium azide.
Availability
Shipped within 3-7 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q8R477
Alias
P-selectin glycoprotein ligand 1,CLA,CD162,PSGL1,PSGL-1,Selectin P ligand
Background
Antibody anti-SELPLG
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

Selectin P ligand (SELPLG), also known as CD162 or P-selectin glycoprotein ligand-1 (PSGL-1), is a critical adhesion molecule that mediates interactions between leukocytes and endothelial cells. Encoded by the SELPLG gene on chromosome 12 in humans, SELPLG plays an essential role in the immune response by facilitating leukocyte tethering and rolling on the endothelium during inflammation and immune surveillance. This glycoprotein ligand interacts with selectins, specifically P-, E-, and L-selectins, which are expressed on activated endothelial cells and platelets, to initiate leukocyte adhesion at inflammation sites. SELPLG's ability to engage in interactions with multiple selectins allows it to participate in a variety of immune functions, from neutrophil recruitment to lymphocyte homing and trafficking. This glycoprotein ligand is particularly important in pathological conditions where leukocyte migration into tissues is crucial, such as infection, inflammation, and tissue injury.